Delivery Order SPE2DB20D3101-SPE2DB22FK0K2
Award Date
6/6/22
Potential Completion Date
6/7/22
Potential Value
$6.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $6,231.97 for the supply of the pharmaceutical product STELARA 45 MG/0.5 ML SYRINGE 0.5ML. The contract has a completion date of December 22, 2023 and was awarded on December 21, 2023. The contracting agency is the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that provides medical supplies and equipment to military healthcare programs. This award is...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $5,061.64, was issued under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $6,680.82 for the supply of STELARA 90 MG/ML SYRINGEML. The award was made by the Defense Logistics Agency (DLA), a defense agency, on September 7, 2022, with a completion date of September 8, 2022. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, valued at $32,477.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. This is a firm-fixed price delivery order contract with a completion date of May 1, 2024. The contract was awarded on April 30, 2024, and does not have a set-aside designation, indicating it was awarded through full and open...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $12,568.40, is for the delivery of STELARA 90 MG/ML SYRINGE/ML medication and is a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of December 5, 2023 and was awarded on December 4, 2023. This contract does not have a set-aside designation, indicating it was awarded through full and open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Stelara 45 mg/0.5 ml syringes. The contract, valued at $3,281.21, is a firm fixed-price delivery order with a completion date of March 22, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $8,982.87 for the supply of STELARA 90 MG/ML SYRINGEML. The award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a civilian agency within the Department of Defense. The contract has an ultimate completion date of December 6, 2023 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition....
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,343.24, is for the delivery of Stelara 45 mg/0.5 ml syringe 0.5 ml, a specialty medication, to support the DLA's medical supply requirements. The contract is a Firm Fixed Price Delivery Order with a completion date of December 27, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $8,337.31 firm fixed-price delivery order is for the supply of STELARA 45 MG/0.5 ML syringes, with a completion date of September 21, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $6,562.44, is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as a primary...